Dr.Ashu Shah a philanthropist,
Entrepreneur & a Doctor said .Autism cause has inspired me to be A Philanthropist ,During my Internship period of time from Manipal Hospital Bangalore in 2007 we use to go for camping in a place called Swanthana
were Autism cases were more than other & I met a mother saying that Iam Drowning in Gratitude cos when i had ist child He was decleared a Autism,then second,then Third too was a cerbral palsy listening from her I really felt people are amazing,Why cant we too be one body part pain were whole body will start responding & Why cant we too Thank to our God for What we are .you know swallowing a Saliva is a blessing, Chewing food,Talking ,Walking is a blessing & Gratitude is an attitude, a mindset. It is recognising that the lens through which we view the world colours what we see. We can choose to focus on the things we dislike and, hence, feel hard done by. Or, we can choose to notice and appreciate the goodness in life, even when things are contrary to our wishes.
The miracle of gratitude is that it shifts our perception and transforms the way we see the world. The joy and happiness it generates within us is enough to slice through the challenges we may face.
I feel blessed, Amazing with Gratitude power completed my Ist project in 2007 Builded a 50 bedded A Special Cerebral palsy Centre with Multidisciplinary Team , Neurologist team & Speech therapist,occupational therapist ,Special Rehab.
Dr.Ashu Shah said:
Austism is primarily a genetic condition: Most of the risk for autism comes from genes1. Mutations in more than 100 genes are known to lead to the condition.
There are four types of tests that can detect these mutations, as well as structural variations that may lead to autism. More of the mutations they find have ties
Here’s a primer on how genetic tests work, their value for autism and what to expect from the results.
A genetic test cannot diagnose or detect autism. That’s because myriad genes along with environmental factors may underlie the condition. Roughly 100 genes have clear ties to autism, but no single gene leads to autism every time it is mutated.
For example, only about one in four people missing a stretch of chromosome 16 called 16p11.2 has autism. This and other mutations are also associated with other conditions, such as epilepsy or intellectual disability.
If a test reveals a harmful mutation with known ties to autism, the result could give the autistic person and her family an explanation for the condition. Some families also find emotional and practical support from others dealing with the same mutation.
There are no drugs tailored to particular autism mutations. But the mutations are often linked to other health problems, such as epilepsy, kidney problems or obesity, so having the information could help prevent or treat those problems.
There are four main types of tests. The oldest is karyotyping, the inspection of chromosomes under a microscope. This test reliably detects changes to segments larger than 10 million base pairs.
A test called chromosomal microarray analysis identifies duplications or deletions of DNA too small to show up on a karyotype. Still, a karyotype is necessary to identify instances in which chromosomes evenly trade a chunk of genetic material.
To detect even smaller duplications or deletions, and single base-pair swaps, clinicians must sequence or scan for mutations across single genes. Some clinicians use commercial autism tests that sequence a predetermined set of genes, but these panels often do not include top autism genes2.
An alternative is to sequence all of a person’s protein-coding DNA, or the exome. Clinicians may sequence the exomes of both parents as well as the child to find mutations present in only the child.
These spontaneous mutations are more likely to contribute to autism than are inherited ones. Exome sequencing is expensive, however, and often not covered by insurance.
Sequencing the entire genome is the most thorough method. It reveals mutations in any part of a person’s genome, not just the 1 percent that includes genes. It is still only a research tool, but as its price falls and it becomes more widely available, it could replace the other tests.
American medical academies recommend only karyotyping or chromosomal microarray analysis for autism. They also advise looking for point mutations in FMR1, MECP2 or PTEN, but only when a child shows other signs of the syndromes associated with mutations in these genes.
Relatively few. Karyotyping finds a relevant mutation in 3 percent of autistic people, and microarray analysis in 10 percent3. Sequencing the three genes associated with syndromes could identify an autism mutation in 14 percent of autistic people Combining these methods with sequencing the exome could yield results in as much as 40 percent of people with autism.
In one 2015 study, microarrays found mutations that could explain autism in 9 percent of children with the condition. Sequencing exomes revealed mutations in another 8 percent4.
The likelihood of finding a known genetic variant increases if the autistic person also has intellectual disability, seizures or unusual facial features.
What if a genetic test turns up nothing?
A negative result does not mean the person does not have a mutation that can cause autism. The test in question might not pick up that particular mutation, or perhaps the mutation does not yet have a known connection to autism.
Many of the genes linked to autism today were not associated with the condition five years ago. Most genetic testing facilities reanalyze results once a year based on the latest findings & its need Multi-disciplinary approach like Neurologist,reanalyzehhritis,Neuro Occupational therapist,Rehab NDT & special education to parents. sequencing, whole-genome sequencing
Counseling can ease shock of unexpected genetic results
City Today News